Skip to main content

Table 1 Description of the study population

From: Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3

Characteristics

All (n = 764)

Age (years)

 

Mean ± SD

52.9 ± 11.8

< 45

176 (23.0%)

45–59

321 (42.0%)

≥ 60

267 (35.0%)

HPV status

 

Unknown or not performed

40 (5.2%)

Negative

109 (14.3%)

HPV16/18

162 (21.2%)

Non-16/18 HR-HPV

453 (59.3%)

Cytology results

 

Unknown or not performed

26 (3.4%)

NILM

535 (70.0%)

LSIL/ASCUS/AGUS

176 (23.0%)

HSIL+/ASC-H

27 (3.6%)

Colposcopic findings

 

Normal

558 (73.0%)

Low-grade lesion

139 (18.2%)

High-grade lesion

43 (5.6%)

Suspicious of cancer

24 (3.2%)

Histology results

 

<CIN2

680 (89.0%)

Normal/ cervicitis

527 (69.0%)

CIN1

153 (20.0%)

CIN2+

84 (11.0%)

CIN2/CIN3

62 (8.1%)

SqCC

18 (2.4%)

AC

4 (0.5%)

Colposcopist

 

Junior

Senior

Indication for colposcopy

525 (68.7%)

239 (31.3%)

Abnormal clinical symptoms

Abnormal vaginal bleeding

Abnormal vaginal discharge

Post-coital bleeding

Unusual appearance of the cervix

Abnormal screening results

91 (11.9%)

31 (4.1%)

19 (2.5%)

25 (3.3%)

16 (2.1%)

673 (88.1%)

  1. NILM, negative for intraepithelial lesion or malignancy; LSIL, low-grade squamous intraepithelial lesion; ASCUS, atypical squamous cells of undetermined significance; AGUS, atypical glandular cells of undetermined significance; ASC-H, atypical squamous cells-cannot exclude HSIL; HSIL, high-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; CIN2, cervical intraepithelial neoplasia grade 2; CIN3, cervical intraepithelial neoplasia grade 3; SD, standard deviation; SqCC, squamous cell carcinoma; AC, adenocarcinoma